Jump to main content
Jump to site search

Issue 24, 2015
Previous Article Next Article

Chemical biology of anticancer gold(III) and gold(I) complexes

Author affiliations

Abstract

Gold complexes have recently gained increasing attention in the design of new metal-based anticancer therapeutics. Gold(III) complexes are generally reactive/unstable under physiological conditions via intracellular redox reactions, and the intracellular AuIII to AuI reduction reaction has recently been “traced” by the introduction of appropriate fluorescent ligands. Similar to most Au(I) complexes, Au(III) complexes can inhibit the activities of thiol-containing enzymes, including thioredoxin reductase, via ligand exchange reactions to form Au–S(Se) bonds. Nonetheless, there are examples of physiologically stable Au(III) and Au(I) complexes, such as [Au(TPP)]Cl (H2TPP = 5,10,15,20-tetraphenylporphyrin) and [Au(dppe)2]Cl (dppe = 1,2-bis(diphenylphosphanyl)ethane), which are known to display highly potent in vitro and in vivo anticancer activities. In this review, we summarize our current understanding of anticancer gold complexes, including their mechanisms of action and the approaches adopted to improve their anticancer efficiency. Some recent examples of gold anticancer chemotherapeutics are highlighted.

Graphical abstract: Chemical biology of anticancer gold(iii) and gold(i) complexes

Back to tab navigation

Publication details

The article was received on 10 Feb 2015 and first published on 14 Apr 2015


Article type: Review Article
DOI: 10.1039/C5CS00132C
Citation: Chem. Soc. Rev., 2015,44, 8786-8801
  •   Request permissions

    Chemical biology of anticancer gold(III) and gold(I) complexes

    T. Zou, C. T. Lum, C. Lok, J. Zhang and C. Che, Chem. Soc. Rev., 2015, 44, 8786
    DOI: 10.1039/C5CS00132C

Search articles by author

Spotlight

Advertisements